ACCD

Accolade, Inc. [ACCD] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

ACCD Stock Summary

Top 10 Correlated ETFs

ACCD


Top 10 Correlated Stocks

ACCD


In the News

08:56 28 Mar 2024 ACCD

Chesapeake Bank receives AARP accolade for combatting financial exploitation

Chesapeake Financial Shares Inc. (OTCQX:CPKF)'s Chesapeake Bank was honored by the American Association of Retired Persons (AARP) for its steadfast efforts in combatting financial exploitation. On March 6, AARP revealed the recognition of Chesapeake Bank among a cohort of 166 banks, credit unions, and financial advisory firms bestowed with the prestigious BankSafe Trained Seal.

08:00 28 Mar 2024 ACCD

Accolade To Present at Upcoming Investor Conferences

SEATTLE, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will be presenting at the following upcoming investor conferences:

02:14 28 Mar 2024 ACCD

Alabama's Fertility Ruling Raises Challenges for Stocks of Fertility Benefits Providers

This week brought another blow for reproductive rights in the U.S. An Alabama Supreme Court handed down a ruling that not only can frozen embryos be classified as “children,” but destroying them can lead to charges of wrongful death. This decision has prompted the University of Alabama at Birmingham, the state's largest healthcare provider, to cease all in vitro fertilization (IVF) treatments.

10:56 28 Mar 2024 ACCD

Does Accolade (ACCD) Have the Potential to Rally 25.58% as Wall Street Analysts Expect?

The consensus price target hints at a 25.6% upside potential for Accolade (ACCD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

07:31 28 Mar 2024 ACCD

4 Top Stocks That Flaunt Solid Earnings Acceleration

Invest in stocks such as AxoGen (AXGN), Western Digital (WDC), Accolade (ACCD) and Credo Technology (CRDO) for superb earnings acceleration.

10:56 28 Mar 2024 ACCD

Wall Street Analysts Predict a 26.85% Upside in Accolade (ACCD): Here's What You Should Know

The consensus price target hints at a 26.9% upside potential for Accolade (ACCD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

09:41 28 Mar 2024 ACCD

Why Accolade (ACCD) Stock Might be a Great Pick

Accolade (ACCD) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

03:23 28 Mar 2024 ACCD

Accolade: Remain Confident That FY25 Guided Growth Is Achievable

I continue to recommend a buy rating with a projected 20% growth in FY25. Recent results show that Accolade beat consensus estimates for revenue and EBITDA, and management expects 20% revenue growth and 2-4% EBITDA margins in FY25. Tailwinds for growth include strong demand for navigation solutions, the health plan channel strategy, GLP-1 growth catalyst, and the recovery in demand for expert medical opinion.

08:00 28 Mar 2024 ACCD

Accolade To Present at Upcoming Investor Conferences

SEATTLE, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will be presenting at the following upcoming investor conferences:

11:18 28 Mar 2024 ACCD

Is Accolade (ACCD) Stock Outpacing Its Business Services Peers This Year?

Here is how Accolade (ACCD) and Adecco SA (AHEXY) have performed compared to their sector so far this year.

ACCD Financial details

Company Rating
Neutral
Market Cap
734.6M
Income
-122.73M
Revenue
388.49M
Book val./share
5.71
Cash/share
3.02
Dividend
-
Dividend %
-
Employees
2.37K
Optionable
No
Shortable
Yes
Earnings
25 Apr 2024
P/E
-9299.42
Forward P/E
-8.47
PEG
6409.96
P/S
2.94
P/B
2625.44
P/C
3.31
P/FCF
-51.58
Quick Ratio
2.19
Current Ratio
2.35
Debt / Equity
0.56
LT Debt / Equity
0.54
-
-
EPS (TTM)
-1.65
EPS next Y
-1.18
EPS next Q
-0.42
EPS this Y
234.2%
EPS next Y
-28.19%
EPS next 5Y
-81.01%
EPS last 5Y
31.67%
Revenue last 5Y
30.81%
Revenue Q/Q
2.59%
EPS Q/Q
-34.88%
-
-
-
-
SMA20
-11.6%
SMA50
-26.05%
SMA100
44.69%
Inst Own
63.8%
Inst Trans
0.84%
ROA
-16%
ROE
-27%
ROC
-0.21%
Gross Margin
45%
Oper. Margin
-35%
Profit Margin
-32%
Payout
-
Shs Outstand
77.41M
Shs Float
69.69M
-
-
-
-
Target Price
19
52W Range
6.33-17.005
52W High
-41.24%
52W Low
+66.5%
RSI
47.55
Rel Volume
0.37
Avg Volume
765.52K
Volume
279.75K
Perf Week
4.83%
Perf Month
-21.46%
Perf Quarter
2.46%
Perf Half Y
-6.72%
-
-
-
-
Beta
2.078
-
-
Volatility
0.17%, 1.06%
Prev Close
0.3%
Price
9.99
Change
1.42%

ACCD Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-02-28

Metric History 2019-02-282020-02-292021-02-282022-02-28 2023-02-28
2.02K2.02K2.02K2.02K2.02K
Revenue per share
2.743.835.84.865.1
Net income per share
-1.63-1.48-1.72-1.93-6.45
Operating cash flow per share
-0.48-0.99-0.86-0.98-0.57
Free cash flow per share
-0.57-1.08-0.94-1.03-0.67
Cash per share
1.232.4314.775.734.51
Book value per share
-6.66-0.6913.3113.416.65
Tangible book value per share
-6.66-0.8613.150.52-0.11
Share holders equity per share
-6.66-0.6913.3113.416.65
Interest debt per share
0.632.170.135.064.45
Market cap
19.05M19.05M1.38B1.15B791.74M
Enterprise value
-4.45M7.04M948.88M1.1B787.45M
P/E ratio
-0.34-0.37-27.3-9.32-1.72
Price to sales ratio
0.20.148.123.72.18
POCF ratio
-1.15-0.56-54.8-18.4-19.45
PFCF ratio
-0.97-0.51-50.11-17.39-16.52
P/B Ratio
-0.08-0.83.541.341.67
PTB ratio
-0.08-0.83.541.341.67
EV to sales
-0.050.055.573.552.17
Enterprise value over EBITDA
0.1-0.18-24.51-8.564.32
EV to operating cash flow
0.27-0.21-37.61-17.66-19.35
EV to free cash flow
0.23-0.19-34.38-16.69-16.43
Earnings yield
-2.97-2.7-0.04-0.11-0.58
Free cash flow yield
-1.03-1.97-0.02-0.06-0.06
Debt to equity
-0.08-3.0400.370.67
Debt to assets
0.30.5800.250.35
Net debt to EBITDA
0.530.311.210.36-0.02
Current ratio
0.831.435.743.663.06
Interest coverage
-22.74-16.48-12.56-58.91532.93
Income quality
0.290.670.50.510.09
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.210.20.190.320.22
Research and developement to revenue
0.380.320.290.270.28
Intangibles to total assets
00.050.010.640.53
Capex to operating cash flow
0.190.10.090.060.18
Capex to revenue
-0.03-0.03-0.01-0.01-0.02
Capex to depreciation
-0.33-0.39-0.29-0.08-0.16
Stock based compensation to revenue
0.060.050.060.240.2
Graham number
15.634.7922.7224.1431.06
ROIC
0.26-1-0.12-0.130.16
Return on tangible assets
-0.86-0.43-0.11-0.27-1.09
Graham Net
-7.3-1.7912.23-0.62-1.21
Working capital
-9.78M30.14M374.91M297.38M246.54M
Tangible asset value
-230.62M-29.84M386.23M33.21M-7.61M
Net current asset value
-249.5M-48.09M369.32M-20.6M-63.33M
Invested capital
-0.08-3.0400.370.67
Average receivables
3.7M812.5K6.51M21.32M28.75M
Average payables
2.04M3.86M6.33M7.61M9M
Average inventory
722K1.28M1.98M2.66M3.52M
Days sales outstanding
1.683.2825.3636.2626.83
Days payables outstanding
14.7926.1228.816.9218.63
Days of inventory on hand
5.478.168.976.517.38
Receivables turnover
217.46111.4414.3910.0713.6
Payables turnover
24.6813.9712.6821.5719.59
Inventory turnover
66.744.7440.6756.0649.45
ROE
0.242.16-0.13-0.14-0.97
Capex per share
-0.09-0.1-0.08-0.06-0.1

Quarterly Fundamentals Overview

Last date of statement is 2023-11-30 for Q3

Metric History 2022-11-302023-02-282023-05-312023-08-31 2023-11-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
1.281.371.271.281.31
Net income per share
-0.56-0.42-0.52-0.43-0.28
Operating cash flow per share
-0.07-0.04-0.26-0.110.07
Free cash flow per share
-0.09-0.07-0.31-0.150.02
Cash per share
4.574.454.143.873.02
Book value per share
6.826.576.215.85.71
Tangible book value per share
-0.08-0.11-0.23-0.32-0.24
Share holders equity per share
6.826.576.215.85.71
Interest debt per share
4.474.384.324.183.2
Market cap
628.95M800.75M881.09M1.02B664.7M
Enterprise value
621.46M796.47M893.62M1.04B676.38M
P/E ratio
-3.94-6.58-5.73-7.76-7.89
Price to sales ratio
6.928.099.4510.516.69
POCF ratio
-134.05-312.92-45.68-126.69127.7
PFCF ratio
-95.25-161.05-38.88-89.93445.21
P/B Ratio
1.291.691.942.331.53
PTB ratio
1.291.691.942.331.53
EV to sales
6.838.049.5910.746.81
Enterprise value over EBITDA
-21.59-40.72-31.93-42.64-81.59
EV to operating cash flow
-132.45-311.24-46.33-129.37129.95
EV to free cash flow
-94.12-160.19-39.43-91.83453.03
Earnings yield
-0.06-0.04-0.04-0.03-0.03
Free cash flow yield
-0.01-0.01-0.03-0.010
Debt to equity
0.650.670.690.720.56
Debt to assets
0.350.350.360.370.31
Net debt to EBITDA
0.260.22-0.45-0.88-1.41
Current ratio
3.143.063.093.082.35
Interest coverage
-104.6231.16-43.03-20.54-18.6
Income quality
0.120.080.50.24-0.25
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.220.20.170.170.16
Research and developement to revenue
0.270.240.280.260.24
Intangibles to total assets
0.540.530.540.540.58
Capex to operating cash flow
0.410.940.180.41-0.71
Capex to revenue
-0.02-0.02-0.04-0.03-0.04
Capex to depreciation
-0.16-0.21-0.29-0.3-0.33
Stock based compensation to revenue
0.20.180.150.160.16
Graham number
9.277.98.567.535.96
ROIC
-0.05-0.04-0.05-0.05-0.04
Return on tangible assets
-0.09-0.07-0.09-0.08-0.06
Graham Net
-1.21-1.2-1.33-1.37-1.3
Working capital
249.62M246.54M235.74M227.26M156.42M
Tangible asset value
-5.81M-7.61M-16.84M-24.24M-18.02M
Net current asset value
-61.61M-63.33M-73.06M-80.42M-78.66M
Invested capital
0.650.670.690.720.56
Average receivables
27.4M25.44M26.5M25.81M25.44M
Average payables
10.54M10.07M7.81M6.28M9.88M
Average inventory
-1.85M160K3.98M4.2M4.47M
Days sales outstanding
23.9324.2625.3923.5223.15
Days payables outstanding
17.8317.99.0711.5520.91
Days of inventory on hand
-6.617.096.537.287.37
Receivables turnover
3.763.713.543.833.89
Payables turnover
5.055.039.937.794.3
Inventory turnover
-13.6212.6913.7812.3612.22
ROE
-0.08-0.06-0.08-0.08-0.05
Capex per share
-0.03-0.03-0.05-0.04-0.05

ACCD Frequently Asked Questions

What is Accolade, Inc. stock symbol ?

Accolade, Inc. is a US stock , located in Plymouth meeting of Pa and trading under the symbol ACCD

Is Accolade, Inc. buy or a sell ?

15 stock analysts have 15 predictions with a medium analyst target price of $19.42. The lowest prediction is $8 and the highest is $52

What is ACCD stock prediction ?

What is Accolade, Inc. stock quote today ?

Accolade, Inc. stock price is $9.99 today.

Is Accolade, Inc. stock public?

Yes, Accolade, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap